Posts by: Ana Pamplona, PhD

Hepatitis C, News

AbbVie’s experimental Hepatitis C oral treatment consisting of the combination of VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) with EXVIERA™ (dasabuvir) with or without ribavirin (RBV), interferon-free, for patients with genotype 1 (GT1) and genotype 4 (GT4) chronic ... Read more

November 19, 2014November 19, 2014

New Study Reveals Insights Into Hepatitis C Antiviral Resistance

Hepatitis C, News

A novel study on how miR-122 inhibition influences HCV replication, entitled “Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors,” was recently published in Nature Communications by Benjamin ... Read more

November 13, 2014November 13, 2014

Phase 2 Study of Chronic Hepatitis C Treatment By Merck Shows Promise

Hepatitis C, News

Data from the C-WORTHY study evaluating the efficacy of treatment with Grazoprevir/Elbasvir of Chronic Hepatitis C in genotype 1 infected treatment-naïve and non-responders to peg-interferon/ribavirin (RP) patients was announced by ... Read more

November 10, 2014November 11, 2014

New Combination Therapy Works Well With Liver Transplants In Hepatitis C

Hepatitis C, News

During the American Association for the Study of Liver Diseases (The Liver Meeting® 2014) to be held in Boston, MA, between November 7 and 11, a new report will be ... Read more

November 6, 2014November 6, 2014

Genotype 1 Chronic Hepatitis C Infection Drug OLYSIO Granted Additional FDA Approval

Hepatitis C, News

The U.S. Food and Drug Administration (FDA) has approved the combination therapy of OLYSIO® (simeprevir), developed by Janssen R&D Ireland and Medivir AB, with sofosbuvir as an alternative treatment for ... Read more

October 28, 2014October 28, 2014

Methadone, Opioid Therapy for Injection-drug Users Found to Reduce HCV Infection

Hepatitis C, News

A new study on the effect of opioid agonist therapy in HCV infection entitled “Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult ... Read more

October 24, 2014October 24, 2014

Chronic Hepatitis B Health Literacy Lagging in Immigrant Patients

Hepatitis B, News

An evaluation study on transmission and consequences of chronic hepatitis B infection entitled “Health literacy in patients with chronic hepatitis B attending a tertiary hospital in Melbourne: a questionnaire based survey” was ... Read more

October 20, 2014October 20, 2014

Hepatitis B Virus Replication, E Antigen Secretion Reduced With Entecavir

Hepatitis B, News

A new promising combination therapy against hepatitis B outlined in a recent study, entitled, “Entecavir combined with turin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion” published in Virology ... Read more

October 16, 2014October 16, 2014

Antibody Identified as Key to Fighting Hepatitis C

Hepatitis C, News

A study on the discovery of neutralizing antibodies to block the hepatitis C virus entitled, “Broadly neutralizing antibodies abrogate established hepatitis C virus infection” may offer a potential therapeutic approach to ... Read more

October 15, 2014October 15, 2014

New Hepatitis C Cure Shows Promise in Small Trial

Hepatitis C, News

Promising data on hepatitis C virus (HCV) genotype 3 therapy was released by Biotron Ltd, an Australian drug development company, showing that treatment with its lead antiviral drug, BIT225, led to ... Read more